Acrobiosystems for English
icon_bulk_orderBulk inquiry/Quick order
0
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > EGF R

EGF R

Brief Information

Name:Epidermal growth factor receptor erbB1
Target Synonym:Epidermal Growth Factor Receptor (Avian Erythroblastic Leukemia Viral (V-Erb-B) Oncogene Homolog),Erythroblastic Leukemia Viral (V-Erb-B) Oncogene Homolog (Avian),Avian Erythroblastic Leukemia Viral (V-Erb-B) Oncogene Homolog,Epidermal Growth Factor Receptor Tyrosine Kinase Domain,Cell Proliferation-Inducing Protein 61,Cell Growth Inhibiting Protein 40,EC 2.7.10.1,NISBD2,PIG61,MENA,EC:2.7.10.1,EC 2.7.10,Receptor tyrosine-protein kinase erbB-1,Proto-oncogene c-ErbB-1,Epidermal growth factor recep
Number of Launched Drugs:31
Number of Drugs in Clinical Trials:155
Lastest Research Phase:Approved

Licensing

Project item Indications Research phase Cooperation demands
BHE202201 Esophageal Carcinoma and Pancreatic Cancer Phase III (Esophageal Carcinoma)\ Phase Ib (Pancreatic Cancer) License-out or co-development for the global right and Clinical development in the US or EU (PK and Phase III)

Product ListCompare or Buy

Cat. No. Species Product Description Structure Purity Feature
EGR-M5257 Mouse Mouse EGF R Protein, Fc Tag (MALS verified)
EGR-M5257-structure
EGR-M5257-sds
EGR-HA2H8 Human APC-Labeled Human EGF R Protein, His TagStar Staining
EGR-H52H5 Human Human EGF R (310-620) Protein, His Tag
EGR-H52H5-structure
EGR-H52H5-sds
EGR-H82E6 Human Biotinylated Human EGF R (310-620) Protein, His,Avitag™
EGR-H82E6-structure
EGR-H82E6-sds
EGR-HP2H7 Human PE-Labeled Human EGF R Protein, His TagStar Staining
EGR-R52H7 Rabbit Rabbit EGF R Protein, His Tag
EGR-R52H7-structure
EGR-R52H7-sds
EGR-H82F8 Human Biotinylated Human EGF R Protein, Fc,Avitag™ (MALS verified)
EGR-H82F8-structure
EGR-H82F8-sds
CHEK-ATF049 Human EGFR (Luc) HEK293 Reporter Cell
EGR-HF256 Human FITC-Labeled Human EGF R Protein, Fc Tag
EGR-HF256-structure
EGR-HF256-sds
EGR-H5259 Human Human EGF R Protein, Llama IgG2b Fc Tag, low endotoxin
EGR-H5259-structure
EGR-H5259-sds
EGR-HP2E3 Human PE-Labeled Human EGF R Protein, His Tag (Site-specific conjugation)
EGR-HP2E3-structure
MBE-K012 Human Human EGFR-coupled Magnetic Beads
EGR-HF2H5 Human FITC-Labeled Human EGF R Protein, His Tag DMF Filed
EGR-HF2H5-structure
EGR-HF2H5-sds
EGR-H522a Human Human EGF R Protein, His Tag, low endotoxin (MALS verified)
EGR-H522a-structure
EGR-H522a-sds
EGR-H82E3 Human Biotinylated Human EGF R Protein, His,Avitag™ (MALS verified)
EGR-H82E3-structure
EGR-H82E3-sds
EGR-C5252 Rhesus macaque Rhesus macaque EGF R Protein, Fc Tag (MALS verified)
EGR-C5252-structure
EGR-C5252-sds
EGR-C52H1 Rhesus macaque Rhesus macaque EGF R Protein, His Tag
EGR-C52H1-structure
EGR-C52H1-sds
EGR-M5224 Mouse Mouse EGF R Protein, His Tag
EGR-M5224-structure
EGR-M5224-sds
EGR-H5252 Human Human EGF R Protein, Fc Tag (MALS verified)
EGR-H5252-structure
EGR-H5252-sds
EGR-H5222 Human Human EGF R Protein, His Tag (MALS verified)
EGR-H5222-structure
EGR-H5222-sds
ACRO Quality

Part of Bioactivity data

EGR-HA2H8-Cell-based assay
 EGF R CAR_T

5e5 of anti-EGFR CAR-293 cells were stained with 100 μL of 1:50 dilution (2 μL stock solution in 100 μL FACS buffer) of APC-Labeled Human EGF R Protein, His Tag (Cat. No. EGR-HA2H8) and negative control protein respectively (Fig. C and B), and non-transfected 293 cells were used as a control (Fig. A). APC signal was used to evaluate the binding activity (QC tested).

EGR-H522a-SPR
Human_FcRn_Heterodimer_Protein_SPR

Immobilized Erbitux on CM5 Chip via anti-human Fc IgG, can bind Human EGF R, His Tag, low endotoxin (Cat.No. EGR-H522a) with an affinity constant of 0.492 nM as determined in SPR assay (Biacore T200) (Routinely tested).

EGR-H522a-SPR
Human_FcRn_Heterodimer_Protein_SPR

Human EGF R, His Tag, low endotoxin (Cat. No. EGR-H522a) captured on CM5 Chip via anti-His antibody can bind Human EGF, Mouse IgG2a Fc Tag (Cat. No. EGF-H525b) with an affinity constant of 2.76 nM as determined in SPR assay (Biacore T200) (Routinely tested).

Synonym Name

EGFR,ERBB,ERBB1,HER1,PIG61,mENA

Background

The epidermal growth factor receptor (EGFR; ErbB-1; HER1 in humans) is the cell-surface receptor for members of the epidermal growth factor family (EGF-family) of extracellular protein ligands. The epidermal growth factor receptor is a member of the ErbB family of receptors, a subfamily of four closely related receptor tyrosine kinases: EGFR (ErbB-1), HER2/c-neu (ErbB-2), Her 3 (ErbB-3) and Her 4 (ErbB-4). Mutations affecting EGFR expression or activity could result in cancer.

Clinical and Translational Updates

Public Drug Information

Name Research Code Research Phase Company First Brand Name First Approved Country First Indication First Approved Company First Approved Date Indications Clinical Trials
Dacomitinib PF-299; PF-804; PF-299804; PF-00299804; PF-00299804-3; PF-00299804-03 Approved Pfizer Inc Vizimpro United States Carcinoma, Non-Small-Cell Lung Pfizer Europe Ma Eeig 2018-09-27 Colorectal Neoplasms; Adenocarcinoma; Neoplasm Metastasis; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Penile Neoplasms; Lung Neoplasms; Esophageal Squamous Cell Carcinoma; Mouth Neoplasms; Head and Neck Neoplasms; Brain Neoplasms; Carcinoma, Large Cell; Liver Diseases; Glioblastoma; Neoplasms; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Solid tumours Details
Cetuximab IMC-C255; BMS-564717; EMD-271786; C-255; GT-MAB-5.2; ch-225; LY-2939777; NSC-714692 Approved Bristol-Myers Squibb Company, Eli Lilly And Company, Merck Serono 爱必妥, Erbitux United States Squamous Cell Carcinoma of Head and Neck Merck Serono Co Ltd 2004-02-12 Endometrial Neoplasms; Oropharyngeal Neoplasms; Peritoneal Neoplasms; Neuralgia; Fallopian Tube Neoplasms; Lung Neoplasms; Esophageal Squamous Cell Carcinoma; Laryngeal Neoplasms; Carcinoma, Squamous Cell; Colorectal Neoplasms; Adenocarcinoma, Mucinous; Neoplasm Metastasis; Carcinoma, Non-Small-Cell Lung; Precancerous Conditions; Complex Regional Pain Syndromes; Carcinoma, Hepatocellular; Gastrointestinal Neoplasms; Colonic Neoplasms; Head and Neck Neoplasms; Neoplastic Cells, Circulating; Liver Neoplasms; Solid tumours; Stomach Neoplasms; Esophageal Neoplasms; Pain; Squamous Cell Carcinoma of Head and Neck; Ovarian Neoplasms; Neoplasms; Pancreatic Neoplasms; Hypopharyngeal Neoplasms; Neoplasms, Squamous Cell; Carcinoma, Adenoid Cystic; Nasopharyngeal Carcinoma; Sarcoma Details
Recombinant Human Epidermal Growth Factor Derivative Eye Drops (Shenzhen Wastin Genetech) Approved Shenzhen Watsin Genetech Ltd 金因舒, GeneSoft Mainland China Corneal Diseases Shenzhen Watsin Genetech Ltd 2004-01-21 Corneal Diseases Details
Recombinant epidermal growth factor gel (Pavay Gene Pharmaceutical) Approved 易孚 Mainland China Skin Ulcer; Burns Guilin Huanuowei Gene Pharmaceutical Co Ltd 2002-12-23 Skin Ulcer; Burns Details
Necitumumab LY-3012211; IMC-11F8 Approved Eli Lilly And Company Portrazza United States Carcinoma, Non-Small-Cell Lung Nippon Kayaku Co Ltd 2015-11-24 Solid tumours; Neoplasms; Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung; Neoplasm Metastasis Details
Recombinant epidermal growth factor (Shanghai Haohai ) Approved Shanghai Haohai Biological Technology Co Ltd 康合素 Mainland China Burns Shanghai Haohai Biological Technology Co Ltd 2001-01-01 Burns Details
PX-070101 PX-070101 Approved Praxis Pharmaceuticals Colombia Diabetic Foot Praxis Pharmaceuticals 2015-07-01 Diabetic Foot Details
Recombinant epidermal growth factor drop (Pavay Gene Pharmaceutical) Approved 易贝 Mainland China Corneal Diseases Guilin Huanuowei Gene Pharmaceutical Co Ltd 2002-04-12 Corneal Diseases; Xerophthalmia Details
Recombinant epidermal growth factor (Center for Genetic Engineering and Biotechnology/Praxis Pharmaceuticals) Approved Praxis Pharmaceuticals, Center For Genetic Engineering And Biotechnology Heberprot-P Cuba Diabetic Foot null 2007-09-01 Diabetic Foot Details
Recombinant epidermal growth factor biosimilar (Elea) r-hu-EGF Approved Elea Argentina Diabetic Foot; Burns Elea 2015-01-01 Diabetic Foot; Burns Details
Epidermal growth factor biosimilar (RAS Lifesciences) Approved Ras Lifesciences India Ras Lifesciences 2012-10-01 Details
Nepidermin DWP-401 Approved Daewoong Pharmaceutical Co Ltd Easyef South Korea Alopecia; Diabetic Foot Daewoong Pharmaceutical Co Ltd 2001-01-01 Diabetic Foot; Alopecia; Dry Eye Syndromes Details
Cetuximab biosimilar (CinnaGen) Approved Cinnagen Iran Colorectal Neoplasms Cinnagen 2017-01-01 Colorectal Neoplasms Details
Recombinant epidermal growth factor (Bharat Biotech) REGEN-D 60; REGEN-D 150 Approved Bharat Biotech International Ltd India Diabetic Foot; Burns Bharat Biotech International Ltd 2005-01-01 Diabetic Foot; Burns Details
Cetuximab sarotalocan RM-1929; ASP-1929 Approved Aspyrian Therapeutics Akalux Japan Head and Neck Neoplasms Rakuten Medical Inc 2020-09-25 Head and Neck Neoplasms; Squamous Cell Carcinoma of Head and Neck Details
Icotinib Hydrochloride BPI-2009H; BPI-2009C Approved Betta Pharmaceuticals Co Ltd 凯美纳, Conmana Mainland China Carcinoma, Non-Small-Cell Lung Betta Pharmaceuticals Co Ltd 2011-06-07 Breast Neoplasms; Neuroma, Acoustic; Adenocarcinoma; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Brain metastases; Esophageal adenocarcinoma; Lung Neoplasms; Carcinoma, Adenosquamous; Solid tumours; Nasopharyngeal Carcinoma; Psoriasis; Adenocarcinoma of Lung; Neurofibromatosis 2; Bronchial Neoplasms; Esophageal Neoplasms; Stomach Neoplasms Details
Lapatinib Ditosylate Hydrate GW-572016; GW-572016F; GW-2016 Approved Glaxosmithkline Plc, Novartis Pharma Ag Tykerb, Tyverb, 泰立沙, Tykerb/Tyverb United States Breast Neoplasms Glaxosmithkline Ag 2007-03-13 Neoplasms, Gonadal Tissue; Carcinoma, Acinar Cell; Carcinoma, Mucoepidermoid; Colorectal Neoplasms; Astrocytoma; Gliosarcoma; Bile Duct Neoplasms; Carcinoma, Squamous Cell; Lymphoma; Glioma; Brain metastases; Lung Neoplasms; Endometrial Neoplasms; Brain Neoplasms; Laryngeal Neoplasms; Gallbladder Neoplasms; Adenocarcinoma; Uterine Cervical Neoplasms; Carcinoma, Hepatocellular; Neoplasm Metastasis; Tongue Neoplasms; Melanoma; Breast Neoplasms, Male; Carcinoma, Non-Small-Cell Lung; Neuroma, Acoustic; Pancreatic Neoplasms; Ovarian Neoplasms; Head and Neck Neoplasms; Ependymoma; Liver Neoplasms; Medulloblastoma; Stomach Neoplasms; Esophageal Neoplasms; Abdominal Neoplasms; Squamous Cell Carcinoma of Head and Neck; Carcinoma, Renal Cell; Carcinoma; Carcinoma, Ovarian Epithelial; Solid tumours; Carcinoma, Verrucous; Glioblastoma; Salivary Gland Neoplasms; Neoplasms; Neurofibromatosis 2; Urinary Bladder Neoplasms; Carcinoma, Adenoid Cystic; Central Nervous System Neoplasms; Oligodendroglioma; Breast Neoplasms; Prost Details
Recombinant Human Epidermal Growth Factor Derivative (Shenzhen Wastin Genetech) rEGF Approved Shenzhen Watsin Genetech Ltd 金因肽, GeneTime Mainland China Wounds and Injuries Shenzhen Watsin Genetech Ltd 2001-01-01 Wounds and Injuries Details
Recombinant human EGF conjugated vaccine Approved Biotech Pharmaceuticals Co Ltd Carcinoma, Non-Small-Cell Lung Details
Mouse epidermal growth factor (Hangzhou Tianmushan Pharmaceutical) Approved Hangzhou Tianmushan Pharmaceutical Enterprise Co Ltd 一夫 Wounds and Injuries Details
Afatinib Dimaleate BIBW-2992; BIBW-2992-MA2 Approved C.H. Boehringer Sohn Ag & Co. Kg Gilotrif, Tomtovok, 吉泰瑞, Tovok, Giotrif United States Carcinoma, Non-Small-Cell Lung Boehringer Ingelheim International Gmbh 2013-07-12 Uterine Neoplasms; Prostatic Neoplasms; Brain Neoplasms; Urethral Neoplasms; Colorectal Neoplasms; Urologic Neoplasms; Ureteral Neoplasms; Lung Neoplasms; Lymphoma; Breast Neoplasms; Glioma; Carcinoma, Squamous Cell; Esophageal Squamous Cell Carcinoma; Gallbladder Neoplasms; Neoplasm Metastasis; Carcinoma, Non-Small-Cell Lung; Adenocarcinoma; Hematologic Neoplasms; Liver Diseases; Urinary Bladder Neoplasms; Chordoma; Multiple Myeloma; Neuroectodermal Tumors; Glioblastoma; Neoplasms; Neoplasms, Squamous Cell; Renal Insufficiency; Squamous Cell Carcinoma of Head and Neck; Esophageal Neoplasms; Stomach Neoplasms; Rhabdomyosarcoma; Head and Neck Neoplasms; Solid tumours Details
Erlotinib Hydrochloride CP-358774-01; RO-0508231; NSC-718781; CP-358774; RG-1415; OSI-774; R-1415 Approved Genentech Inc Tarceva, 特罗凯 United States Pancreatic Neoplasms; Carcinoma, Non-Small-Cell Lung Osi Pharmaceuticals Llc 2004-11-18 Colorectal Neoplasms; Lung Neoplasms; Brain metastases; Carcinoma, Squamous Cell; Fallopian Tube Neoplasms; Glioma; Bile Duct Neoplasms; Urologic Neoplasms; Carcinoma, Mucoepidermoid; Ureteral Neoplasms; Gliosarcoma; Oropharyngeal Neoplasms; Neuroectodermal Tumors, Primitive; Esophageal adenocarcinoma; Adenocarcinoma, Bronchiolo-Alveolar; Astrocytoma; Glioma, Subependymal; Metaplasia; Psoriasis; Osteosarcoma; Sarcoma; Urethral Neoplasms; Neuroblastoma; Prostatic Neoplasms; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Neoplasms, Germ Cell and Embryonal; Melanoma; Breast Neoplasms, Male; Carcinoma, Hepatocellular; Carcinoma, Endometrioid; Tongue Neoplasms; Meningioma; Precancerous Conditions; Uterine Cervical Neoplasms; Adenocarcinoma; Neoplasm Metastasis; Cholangitis, Sclerosing; Lip Neoplasms; Gallbladder Neoplasms; Lymphoma; Esophageal Squamous Cell Carcinoma; Mouth Neoplasms; Laryngeal Neoplasms; Adenomatous Polyps; Paranasal Sinus Neoplasms; Adenocarcinoma, Mucinous; Neoplasms, Unknown Primary; Endomet Details
Brigatinib AP-26113 Approved Ariad, Takeda Pharmaceutical Co Ltd Alunbrig United States Carcinoma, Non-Small-Cell Lung Takeda Pharmaceuticals U.S.A. Inc 2017-04-28 Ependymoma; Solid tumours; Carcinoma; Neoplasms; Neurofibromatosis 2; Myofibroma; Lung Neoplasms; Lymphoma, Large-Cell, Anaplastic; Brain metastases; Granuloma, Plasma Cell; Carcinoma, Non-Small-Cell Lung; Meningioma; Neurilemmoma; Neuroma, Acoustic; Sarcoma, Kaposi Details
Gefitinib ZD-1839 Approved Astrazeneca Pharmaceutical Co Ltd 易瑞沙, Iressa Japan Carcinoma, Non-Small-Cell Lung Astrazeneca Pharmaceutical Co Ltd 2002-07-05 Fallopian Tube Neoplasms; Gastrinoma; Prostatic Neoplasms; Brain Neoplasms; Urethral Neoplasms; Breast Neoplasms; Astrocytoma; Gliosarcoma; Colorectal Neoplasms; Adenocarcinoma, Bronchiolo-Alveolar; Carcinoma, Mucoepidermoid; Lung Neoplasms; Neoplasms, Neuroepithelial; Glioma; Carcinoma, Adenosquamous; Endometrial Neoplasms; Carcinoma, Squamous Cell; Leukemia, Myeloid, Acute; Brain metastases; Carcinoma, Non-Small-Cell Lung; Neoplasms, Germ Cell and Embryonal; Uterine Cervical Neoplasms; Breast Neoplasms, Male; Gastrointestinal Neoplasms; Carcinoma, Hepatocellular; Somatostatinoma; Neoplasm Metastasis; Adenocarcinoma; Glioblastoma; Liver Neoplasms; Solid tumours; Kidney Neoplasms; Ovarian Neoplasms; Carcinoma, Islet Cell; Vipoma; Insulinoma; Carcinoid Tumor; Abdominal Neoplasms; Carcinoma, Renal Cell; Esophageal Neoplasms; Carcinoma; Stomach Neoplasms; Head and Neck Neoplasms; Skin Neoplasms; Neoplasms; Carcinoma, Transitional Cell; Adenocarcinoma of Lung; Small Cell Lung Carcinoma; Salivary Gland Neoplasms; Details
Pyrotinib Maleate HTI-1001; SHR-1258; BLTN Approved Jiangsu Hengrui Medicine Co Ltd 艾瑞妮 Mainland China Breast Neoplasms Jiangsu Hengrui Medicine Co Ltd 2018-08-12 Solid tumours; Biliary Tract Neoplasms; Esophageal Neoplasms; Stomach Neoplasms; Adenocarcinoma of Lung; Neoplasms; Breast Neoplasms; Bile Duct Neoplasms; Metastatic breast cancer; Lung Neoplasms; Carcinoma, Non-Small-Cell Lung; Gastrointestinal Neoplasms Details
Neratinib Maleate CAN-030; HKI-272; PF-0528767; WAY-179272; PB-272 Approved Pfizer Pharmaceuticals Ltd (China) Nerlynx, 贺俪安 United States Breast Neoplasms Puma Biotechnology Inc 2017-07-17 Solid tumours; Neoplasms; Prostatic Neoplasms, Castration-Resistant; Breast Neoplasms; Prostatic Neoplasms; Hepatic Insufficiency; Colorectal Neoplasms; Lung Neoplasms; Metastatic breast cancer; Brain metastases; Carcinoma, Non-Small-Cell Lung Details
Panitumumab ABX-0303; E7.6.3; AMG-954; ABX-EGF; ABX-10221 Approved Amgen Inc Vectibix United States Colorectal Neoplasms Amgen Inc 2006-09-27 Salivary Gland Neoplasms; Gastrointestinal Neoplasms; Exanthema; Carcinoma, Non-Small-Cell Lung; Neoplasm Metastasis; Glioma; Carcinoma, Squamous Cell; Lung Neoplasms; Adenoma, Pleomorphic; Colorectal Neoplasms; Brain Neoplasms; Prostatic Neoplasms; Kidney Neoplasms; Malignant Carcinoid Syndrome; Pancreatic Neoplasms; Colonic Neoplasms; Neoplasms; Squamous Cell Carcinoma of Head and Neck; Carcinoma, Renal Cell; Carcinoma; Rectal Neoplasms; Esophageal Neoplasms; Head and Neck Neoplasms; Solid tumours Details
Lazertinib YH-25448; JNJ-73841937; JNJ-1937; GNS-1480 Approved Oscotec Inc, Janssen Biotech Inc, Yuhan Corp Leclaza South Korea Carcinoma, Non-Small-Cell Lung Yuhan Corp 2021-01-18 Hepatic Insufficiency; Carcinoma, Non-Small-Cell Lung Details
Nimotuzumab OSAG-10; KI-0502; KI-0501; DE-766; YMB-1000; OSAG-101; h-R3; TheraCIMh-R3 Approved Center Of Molecular Immunology, Cimym Biosciences Theraloc, BIOMAb-EGFR, TheraCIM, 泰欣生, CIMAher India Nasopharyngeal Neoplasms; Head and Neck Neoplasms null 2006-07-21 Solid tumours; Head and Neck Neoplasms; Squamous Cell Carcinoma of Head and Neck; Anus Neoplasms; Neoplasms; Pancreatic Neoplasms; Nasopharyngeal Neoplasms; Pancreatic neuroendocrine tumors (pNET); Nasopharyngeal Diseases; Nasopharyngeal Carcinoma; Esophageal Squamous Cell Carcinoma; Glioma; Carcinoma, Squamous Cell; Carcinoma, Non-Small-Cell Lung; Uterine Cervical Neoplasms; Esophageal Diseases Details
Osimertinib Mesylate AZD-9291; RDL94R2A16; AZD-9291 Mesylate; AZD9291 Approved Astrazeneca Pharmaceutical Co Ltd 泰瑞沙, Tagrisso United States Carcinoma, Non-Small-Cell Lung Astrazeneca Pharmaceutical Co Ltd 2015-11-13 Uterine Neoplasms; Prostatic Neoplasms; Breast Neoplasms; Meningeal Neoplasms; Colorectal Neoplasms; Carcinoma, Squamous Cell; Lung Neoplasms; Brain metastases; Esophageal adenocarcinoma; Cholangiocarcinoma; Lymphoma; Glioma; Endometrial Neoplasms; Thyroid Neoplasms; Adenocarcinoma; Carcinoma, Non-Small-Cell Lung; Uterine Cervical Neoplasms; Melanoma; Adenocarcinoma of Lung; Liver Neoplasms; Ovarian Neoplasms; Squamous Cell Carcinoma of Head and Neck; Carcinoma, Renal Cell; Rectal Neoplasms; Stomach Neoplasms; Esophageal Neoplasms; Neoplasms; Solid tumours; Carcinoma, Ovarian Epithelial; Carcinoma, Transitional Cell; Pancreatic Neoplasms; Skin Neoplasms; Colonic Neoplasms; Glioblastoma; Multiple Myeloma; Urinary Bladder Neoplasms Details
Amivantamab JNJ-372; JNJ-61186372 Approved Janssen Global Services Llc, Genmab A/S RYBREVANT United States Carcinoma, Non-Small-Cell Lung Janssen Biotech Inc 2021-05-21 Solid tumours; Stomach Neoplasms; Esophageal Neoplasms; Colorectal Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung Details

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
Antroquinonol Phase 2 Clinical Pancreatic Neoplasms; Coronavirus Disease 2019 (COVID-19); Hepatitis B; Leukemia, Myeloid, Acute; Carcinoma, Non-Small-Cell Lung; Hyperlipidemias; Dermatitis, Atopic Details
Cetuximab biosimilar (R-Pharm) RPH-002 Phase 3 Clinical R-Pharm Head and Neck Neoplasms; Pancreatic Neoplasms Details
D2C7-based immunotoxins (Duke University) D2C7-IT; scds-D2C7 -PE38KDEL; D2C7-(scdsFv)-PE38 KDEL Phase 1 Clinical Istari Oncology Inc, Duke University Glioma Details
WSD-0922 WSD0922; WSD-0922 Phase 1 Clinical Vision Biological Tech (Hefei) Co Ltd Glioblastoma; Glioma Details
CKD-702 Phase 1 Clinical Chong Kun Dang Pharmaceutical Corp Carcinoma, Non-Small-Cell Lung Details
Cetuximab-IRDye800CW (University Medical Center Groningen) Phase 1 Clinical Umcg The University Medical Center Groningen Rectal Neoplasms; Penile Neoplasms Details
Anti-CTLA-4/PD-1 expressing EGFR-CAR-T Phase 2 Clinical Shanghai Cell Therapy Research Institute Solid tumours Details
Puvitinib Phase 1 Clinical Suzhou Teligene Ltd Solid tumours Details
BNA-035 BNA-035 Phase 1 Clinical Binacea Pharma Inc Solid tumours Details
ERAS-801 ERAS-801 Phase 1 Clinical Regents Of The University Of California Glioblastoma Details
REGN-7075 REGN-7075 Phase 2 Clinical Regeneron Pharmaceuticals Inc Solid tumours; Neoplasms Details
HS-10376 Phase 2 Clinical Jiangsu Hansoh Pharmaceutical Group Co Ltd Solid tumours; Carcinoma, Non-Small-Cell Lung Details
DAJH-1050766 DAJH-1050766; DAJH1050766 Phase 2 Clinical Chengdu Diao Jiuhong Pharmaceutical Factory Carcinoma, Non-Small-Cell Lung Details
Anti-EGFR-IL-dox (Swiss Group for Clinical Cancer Research) Phase 2 Clinical Schweizerische Arbeitsgemeinschaft Für Klinische Krebsforschung Breast Neoplasms Details
Recombinant anti-InE monoclonal antibody CmAb-(IL10)2 Phase 1 Clinical Dingfu Biotarget Co Ltd Solid tumours Details
AMX-3009 Maleate AMX-3009; AMX3009马来酸 Phase 1 Clinical Anrun Medicine Technology (Suzhou) Co Ltd Solid tumours; Stomach Neoplasms; Pancreatic Neoplasms; Breast Neoplasms Details
Anti-EGFR-bispecific antibody armed activated T-cell therapy (Memorial Sloan Kettering Cancer Center) Phase 1 Clinical Memorial Sloan Kettering Cancer Center Pancreatic Neoplasms Details
SGT-210 SGT-210 Phase 1 Clinical Sol Gel Technologies Pte Ltd Keratosis Details
Anti-EGFR CAR T-cell therapy (Seattle Children's Hospital) EGFR-806 Phase 1 Clinical Seattle Children'S Hospital Central Nervous System Neoplasms Details
TQB-3456 TQB-3456 Phase 1 Clinical Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd, Lianyungang Runzhong Pharmaceutical Co Ltd Carcinoma, Non-Small-Cell Lung Details
MP-0274 DARPin-41; SPA-28; CME-114; CME-115; CME-118; CME-119; MP-0274 Phase 1 Clinical Molecular Partners Ag Neoplasms Details
Cetuximab biosimilar (Enzene Biosciences) Clinical Enzene Biosciences Ltd Carcinoma, Squamous Cell Details
Nimotuzumab biosimilar (IBC Generium) Phase 3 Clinical International Biotechnology Center Generium Llc Head and Neck Neoplasms Details
Durvalumab/Gefitinib Phase 2 Clinical Medimmune Carcinoma, Non-Small-Cell Lung Details
CART-EGFR-IL13Ra2 CART-EGFR-IL13Ra2; CAR-T-EGFR-IL-13-Ra-2 Phase 1 Clinical University Of Pennsylvania Glioblastoma Details
BC-3448 BC-3448; BC3448 Phase 1 Clinical Wuxi Zhikang Hongyi Biological Technology Co Ltd Solid tumours Details
YK-029A YK-029A Phase 1 Clinical Hainan Yuekang Biomedicine Co Ltd Carcinoma, Non-Small-Cell Lung Details
AP-L1898 JS111; AP-L1898; WJ-002 Phase 2 Clinical Wigen Biomedicine technology (Shanghai) Co Ltd Lung Neoplasms; Carcinoma, Non-Small-Cell Lung Details
Epitinib Succinate HMPL-813 Phase 1 Clinical Hutchison Medipharma Ltd Solid tumours; Neoplasms; Glioblastoma; Carcinoma, Non-Small-Cell Lung Details
Nazartinib EGF-816; EGFRmut-TKI EGF816 Phase 2 Clinical Novartis Pharma Ag Bronchial Neoplasms; Triple Negative Breast Neoplasms; Colorectal Neoplasms; Lung Neoplasms; Carcinoma, Non-Small-Cell Lung; Adenocarcinoma Details
Recombinant chimeric anti-EGFR monoclonal antibody (Qilu Pharmaceutical) QL-1105 Phase 1 Clinical Qilu Pharmaceutical Co Ltd Solid tumours Details
Betatinib TL-512 Phase 1 Clinical Aspedia Llc, Suzhou Teligene Ltd Carcinoma, Non-Small-Cell Lung Details
BL-B01D1 Phase 1 Clinical Sichuan Baili Pharmaceutical Co Ltd Neoplasms, Fibroepithelial; Solid tumours; Neoplasms; Digestive System Neoplasms; Breast Neoplasms; Urologic Neoplasms; Gastrointestinal Neoplasms Details
Panitumumab-IRDye800CW (Stanford University) Phase 2 Clinical Stanford University Head and Neck Neoplasms; Brain Neoplasms Details
QL1203 QL-1203 Phase 3 Clinical Qilu Pharmaceutical Co Ltd Colorectal Neoplasms Details
BPI-361175 BPI-361175 Phase 2 Clinical Betta Pharmaceuticals Co Ltd Carcinoma, Non-Small-Cell Lung Details
Bafisontamab FIT-013a; EMB-01 Phase 2 Clinical Shanghai Epimab Biotherapeutics, Inc Liver Neoplasms; Biliary Tract Neoplasms; Carcinoid Tumor; Stomach Neoplasms; Neoplasms; Digestive System Neoplasms; Colorectal Neoplasms; Lung Neoplasms; Carcinoma, Non-Small-Cell Lung; Neoplasm Metastasis; Gastrointestinal Neoplasms; Carcinoma, Hepatocellular Details
H-002 H-002 Phase 2 Clinical Nanjing Hongyun Biological Technology Co Ltd Neoplasms; Carcinoma, Non-Small-Cell Lung Details
BDTX-1535 BDTX-1535 Phase 1 Clinical Black Diamond Therapeutics Inc Glioblastoma; Carcinoma, Non-Small-Cell Lung Details
BEBT-109 BEBT-109 Phase 2 Clinical Guangzhou BeBetter Medicine Technology Co Carcinoma, Non-Small-Cell Lung Details
GC-1118A GC-1118; GC-1118A Phase 2 Clinical Korean Green Cross Corp Solid tumours; Stomach Neoplasms; Colorectal Neoplasms; Neoplasm Metastasis Details
WJ-13404 WJ-13404; JS-113; WJ-004 Phase 2 Clinical Wigen Biomedicine technology (Shanghai) Co Ltd Carcinoma, Non-Small-Cell Lung Details
Cetuximab biosimilar (AMPO Biotechnology) Phase 3 Clinical Ampo Biotechnology Inc Colorectal Neoplasms Details
Sapitinib AZD-8931 Phase 2 Clinical Astrazeneca Pharmaceutical Co Ltd Solid tumours; Stomach Neoplasms; Esophageal Neoplasms; Neoplasms; Breast Neoplasms; Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung; Neoplasm Metastasis Details
Cetuximab biosimilar (Shanghai Zhangjiang Biotechnology) STI-001; CMAB-009 Phase 3 Clinical Shanghai Zhangjiang Biotechnology Co Ltd Neoplasms; Colorectal Neoplasms Details
TQB3804 TQB-3804 Phase 1 Clinical Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd Solid tumours; Neoplasms; Neoplasm Metastasis; Carcinoma, Non-Small-Cell Lung Details
[111In] Panitumumab Phase 1 Clinical Stanford University Head and Neck Neoplasms Details
EGFR IL12 CART Phase 1 Clinical Colorectal Neoplasms Details
Cetuximab biosimilar (Guilin Sanjin) CDP-1; BC-001 Phase 1 Clinical Dragonboat Biopharmaceutical, Guilin Sanjin Pharmaceutical Co Ltd Solid tumours; Neoplasms; Colorectal Neoplasms Details
NX-019 NX-019 Phase 1 Clinical Nalo Therapeutics Inc Neoplasms Details
ZN-e4 ZN-e4; KP-673 Phase 2 Clinical Zentalis Pharmaceuticals LLC, Zeno Pharma Carcinoma, Non-Small-Cell Lung Details
QLH-11811 QLH-11811; QLH11811 Phase 1 Clinical Qilu Pharmaceutical Co Ltd Carcinoma, Non-Small-Cell Lung Details
TAK-186 EGFR x CD3 COBRA; MVC-101; TAK-186 Phase 2 Clinical Takeda Pharmaceutical Co Ltd Solid tumours; Squamous Cell Carcinoma of Head and Neck; Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung Details
FCN-411 FCN-411 Phase 2 Clinical Shanghai Fosun Pharmaceutical (Group) Co Ltd Lung Neoplasms; Carcinoma, Non-Small-Cell Lung Details
Immunomodulatory progenitor cell therapy (Celixir) Phase 3 Clinical Celixir Endomyocardial Fibrosis; Cardiomyopathies Details
CX-904 CX-904 Phase 1 Clinical Amgen Inc, Cytomx Therapeutics Inc Solid tumours; Neoplasms Details
C225-ILS-DOX C225-ILs-dox Phase 2 Clinical Universitaetsspitals Basel Breast Neoplasms Details
AFM-24 AFM-24 Phase 2 Clinical Affimed Solid tumours Details
HER-1 vaccine (Center of Molecular Immunology) HER1-ECD; HER1-VSSP; HER-1-ECD-VSSP Phase 2 Clinical Center Of Molecular Immunology Neoplasms Details
Olafertinib CK-101; RX-518; CS-2481; EGFR-IN-3 Phase 3 Clinical Suzhou Neupharma Co Ltd Lung Diseases; Lung Neoplasms; Adenocarcinoma; Carcinoma, Non-Small-Cell Lung Details
Losatuxizumab vedotin ABBV221; ABBV-221 Phase 1 Clinical Abbvie Inc Neoplasms Details
Hemay-020 Hemay-020 Phase 1 Clinical Tianjin Hemay Pharmaceutical Co Ltd, Hainan General Sanyang Pharmaceutical Co Ltd Solid tumours; Carcinoma, Non-Small-Cell Lung Details
Epertinib S-222611 Phase 2 Clinical Shionogi & Co Ltd Neoplasms Details
BPI-15086 BPI-15000; BPI-15086 Phase 1 Clinical Betta Pharmaceuticals Co Ltd Carcinoma, Non-Small-Cell Lung Details
ORIC-114 ORIC-114 Phase 1 Clinical Voronoi Solid tumours; Carcinoma, Non-Small-Cell Lung Details
Recombinant anti-EGFR chimeric antibody (Harbin Pharmaceutical) Phase 1 Clinical Harbin Pharmaceutical Group Holding Co Ltd Colorectal Neoplasms Details
BLU-701 BLU 701; BLU-701 Phase 2 Clinical Blueprint Medicines Corp Carcinoma, Bronchogenic; Carcinoma; Thoracic Neoplasms; Bronchial Neoplasms; Respiratory Tract Diseases; Neoplasms; Lung Diseases; Respiratory Tract Neoplasms; Neoplasms, Nerve Tissue; Lung Neoplasms; Carcinoma, Non-Small-Cell Lung; Adenocarcinoma Details
KSP-QRH-E3-IRDye800 Phase 1 Clinical University Of Michigan Cholangiocarcinoma Details
KY-1701 KY-1701 Phase 1 Clinical Jiangsu Kanion Pharmaceutical Co Ltd Breast Neoplasms Details
Antibody-drug nanocell conjugates (EnGeneIC) EGFR-EDV-RRM1; EGFR-EDV-PLK; EGFR-EDV-Dox Phase 1 Clinical Engeneic Ltd Glioblastoma Details
FWD1509 MsOH FWD1509 MsOH Phase 2 Clinical Shenzhen Forward Pharmaceuticals Co Ltd Carcinoma, Non-Small-Cell Lung Details
ABY-029 ABY-029 Phase 1 Clinical Dartmouth College, Affibody Ab, Li-Cor Bioscience Head and Neck Neoplasms; Sarcoma; Glioma Details
HS-10375 HS-10375 Phase 2 Clinical Jiangsu Hansoh Pharmaceutical Group Co Ltd Carcinoma, Non-Small-Cell Lung Details
EGFRvIII-CAR Phase 1 Clinical Duke University Medical Center Glioblastoma Details
Autologous EGFR-CAR T cells (Bio-gene) Phase 1 Clinical Sun Yat-Sen University, Guangzhou Bio-Gene Technology Co Ltd Carcinoma, Non-Small-Cell Lung Details
PLB-1004 PLB-1004 Phase 1 Clinical Beijing Anshi Biotechnology Co Ltd Carcinoma, Non-Small-Cell Lung Details
Cetuximab biosimilar (AlphaMab) KN-005 Phase 3 Clinical Suzhou Alphamab Co Ltd Head and Neck Neoplasms; Anus Neoplasms; Urinary Bladder Neoplasms; Colorectal Neoplasms Details
Double-deleted Vaccinia Virus Plus CD/ SMR JX-929; vvDD-CDSR Phase 1 Clinical Sillajen Inc Liver Neoplasms; Squamous Cell Carcinoma of Head and Neck; Pancreatic Neoplasms; Breast Neoplasms; Colorectal Neoplasms; Melanoma Details
Simotinib Hydrochloride AL-6802; SIM-6802 Phase 1 Clinical Jiangsu Simcere Pharmaceutical Co Ltd, Advenchen Laboratories Llc Carcinoma, Non-Small-Cell Lung Details
EG-007 EG-007 Phase 3 Clinical Evergreen Therapeutics Inc Endometrial Neoplasms Details
GB-263 GB-263; GB-263T Phase 2 Clinical Genor Biopharma Co Ltd Solid tumours; Neoplasms; Carcinoma, Non-Small-Cell Lung Details
Sirotinib Maleate XZP-5491 Phase 1 Clinical Stomach Neoplasms; Carcinoma, Squamous Cell; Carcinoma, Non-Small-Cell Lung Details
ZZ-06 ZZ-06 Phase 1 Clinical Changchun Intellicrown Pharmaceutical Co Ltd Solid tumours Details
BLU-451 BLU-451 Phase 2 Clinical Blueprint Medicines Corp Carcinoma, Bronchogenic; Bronchial Neoplasms; Carcinoma; Respiratory Tract Diseases; Neoplasms; Lung Diseases; Respiratory Tract Neoplasms; Neoplasms, Nerve Tissue; Lung Neoplasms; Carcinoma, Non-Small-Cell Lung; Adenocarcinoma Details
Humanized anti-EGFR monoclonal antibody (Hualan Biological Engineering/Henan shengming biotechnology) Phase 2 Clinical Henan Shengming Biotechnology Research Institute Co Ltd, Hualan Genetic Engineering Co Ltd Colorectal Neoplasms Details
ZSP-0391 ZSP-0391 Phase 1 Clinical Wuxi Apptec Co Ltd, Guangdong Zhongsheng Pharmaceutical Co Ltd Carcinoma, Non-Small-Cell Lung Details
EGFR/B7H3 CAR-T EGFR/B7H3 CAR-T Phase 1 Clinical Second Affiliated Hospital Of Guangzhou Medical University Triple Negative Breast Neoplasms; Lung Neoplasms Details
JMT101 JMT-101 Phase 3 Clinical Shanghai Jinmante Biological Technology Co Ltd Solid tumours; Esophageal Squamous Cell Carcinoma; Carcinoma, Non-Small-Cell Lung Details
Demupitamab SCT-200 Phase 2 Clinical SinoCelltech Ltd Solid tumours; Head and Neck Neoplasms; Biliary Tract Neoplasms; Ovarian Neoplasms; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Carcinoma, Renal Cell; Carcinoma; Pancreatic Neoplasms; Neoplasms; Triple Negative Breast Neoplasms; Colorectal Neoplasms; Esophageal Squamous Cell Carcinoma; Gallbladder Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Hepatocellular Details
NIP-142 NIP-142 Phase 1 Clinical National Institutes Of Pharmaceutical Research And Development Co Ltd Carcinoma, Non-Small-Cell Lung Details
SYN-004 (Synermore Biologics) LR-004; SYN-004 Phase 1 Clinical Lonn Ryonn Pharma Ltd, Synermore Biologics (Suzhou) Co Ltd Solid tumours; Carcinoma; Lymphoma, Large B-Cell, Diffuse; Colorectal Neoplasms Details
LY-01010 LY-01010 Phase 1 Clinical Luye Pharma Group Ltd Breast Neoplasms Details
Futuximab/Modotuximab Sym-004; S95026; S-95026; 992-and-1024 Phase 3 Clinical Symphogen A/S Solid tumours; Carcinoma; Squamous Cell Carcinoma of Head and Neck; Colorectal Neoplasms; Glioma Details
Tesevatinib XL-647; KD-020; KD-019; EXEL-7647 Phase 2 Clinical Exelixis Inc Neoplasms; Glioblastoma; Breast Neoplasms; Brain Neoplasms; Polycystic Kidney, Autosomal Dominant; Brain metastases; Polycystic Kidney, Autosomal Recessive; Carcinoma, Non-Small-Cell Lung; Neoplasm Metastasis Details
NRC-2694 NRC-2694; NRC-2694A; NRC-2694-A Phase 2 Clinical Natco Pharma Carcinoma; Squamous Cell Carcinoma of Head and Neck Details
SKLB-1028 SKLB-1028 Phase 3 Clinical Sichuan University, CSPC Pharmaceutical Group Ltd Solid tumours; Leukemia, Promyelocytic, Acute; Leukemia, Myeloid; Leukemia, Myeloid, Acute Details
PB-357 PB-357 Phase 1 Clinical Pfizer Inc Neoplasms Details
BB-101 (Blue Blood Biotech/National Cheng Kung University) BB-101 Phase 1 Clinical National Cheng Kung University, Blue Blood Biotech Corp Diabetic Foot Details
ABBV-637 ABBV-637 Phase 1 Clinical Abbvie Inc Solid tumours; Carcinoma, Non-Small-Cell Lung Details
Pirotinib Hydrochloride KBP-5209 Phase 2 Clinical Solid tumours; Neoplasms; Breast Neoplasms; Lung Neoplasms; Carcinoma, Non-Small-Cell Lung Details
BBT-176 BBT-176 Phase 2 Clinical Bridge Biotherapeutics Inc Carcinoma, Non-Small-Cell Lung Details
JRF-103 JRF103; JRF-103 Phase 2 Clinical Shenzhen Jinrui Foundation Biotechnology Co Ltd Solid tumours Details
TAS-6417 CLN-081; TAS-6417 Phase 2 Clinical Taiho Pharmaceutical Co Ltd Carcinoma, Non-Small-Cell Lung Details
Larotinib Mesylate Z-650 Phase 3 Clinical Guangdong Dongyangguang Pharmaceutical Co Ltd Solid tumours; Esophageal Neoplasms; Pancreatic Neoplasms; Esophageal Squamous Cell Carcinoma Details
SMET-12 SMET-12 Phase 1 Clinical Zhejiang Shimai Pharmaceutical Co Ltd Solid tumours Details
Cetuximab biosimilar (Humanwell Healthcare) Phase 1 Clinical Colorectal Neoplasms Details
Neptinib Di-P-methylbenzenesulfonate Phase 1 Clinical Shenzhen Neptunus Pharmaceutical Research Institute Co Ltd Stomach Neoplasms; Breast Neoplasms; Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung Details
Lifirafenib BeiGene-283; BGB-283 Phase 2 Clinical Beigene Ltd Solid tumours Details
Selatinib Ditosilate QLNC-120 Phase 2 Clinical Qilu Antibiotics (Linyi) Pharmaceutical Co Ltd, Qilu Pharmaceutical Co Ltd Breast Neoplasms Details
Anti-CD3/anti-EGFR -activated T cells (Barbara Ann Karmanos Cancer Institute) Phase 2 Clinical Barbara Ann Karmanos Cancer Institute, University Of Virginia Glioblastoma; Pancreatic Neoplasms Details
E-EDV-D682 PNU-15982; E-EDV-D682; EGFR-EDV-PNU-15982 Phase 2 Clinical Engeneic Ltd Pancreatic Neoplasms Details
Allitinib Tosylate AST-6; ALS-1306; AST-1306 Phase 2 Clinical Shanghai Allist Pharmaceutical Technology Co Ltd Breast Neoplasms; Carcinoma, Non-Small-Cell Lung Details
Cetuximab biosimilar (Kelun Group) KL-A140; KLA140; A-140; KL-140; KLA-140 Phase 3 Clinical Sichuan Kelun Pharmaceutical Co Ltd Rectal Neoplasms; Cholangiocarcinoma; Colorectal Neoplasms; Adenocarcinoma Details
Anti-EGFR CAR-T cell therapy (Beijing Pregene) Phase 2 Clinical Colorectal Neoplasms Details
M-1231 M-1231 Phase 1 Clinical Emd Serono Research & Development Institute Inc, Merck Serono Solid tumours; Esophageal Neoplasms; Carcinoma, Non-Small-Cell Lung Details
IAE-0972 IAE-0972 Phase 2 Clinical Shenghe (China) Biopharmaceutical Co Ltd Solid tumours Details
DWP-708 DWP-708 Phase 2 Clinical Daewoong Pharmaceutical Co Ltd Acneiform Eruptions Details
Recombinant anti-EGFR chimeric monoclonal antibody (Shanghai CP Guojian) CPGJ-602; 602; CPGJ602; CPGJ 602 Phase 2 Clinical Sunshine Guojian Pharmaceutical (Shanghai) Co Ltd Colorectal Neoplasms Details
Petosemtamab MCLA-158 Phase 1 Clinical Merus Nv Neoplasms; Colorectal Neoplasms Details
TAS-2940 TAS-2940 Phase 1 Clinical Taiho Oncology Inc Solid tumours; Glioblastoma; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung Details
Recombinant chimeric anti-EGFR monoclonal antibody (Zhejiang Xinwei Shengke Biotechnology) Phase 1 Clinical Zhejiang Xinweishengke Biotechnology Co Ltd Esophageal Neoplasms Details
[89Zr]Panitumumab (University of Alabama at Birmingham) Phase 1 Clinical University Of Alabama At Birmingham Squamous Cell Carcinoma of Head and Neck; Colonic Neoplasms; Pancreatic Neoplasms Details
TAVO-412 TAVO-412 Phase 1 Clinical Tavotek Biotherapeutics (Hong Kong) Ltd Neoplasms Details
CMAB-017 CMAB-017 Phase 1 Clinical Taizhou Mabtech Pharmaceutical Co Ltd Solid tumours Details
Izalontamab SI-B001; SI-1X6.4 Phase 3 Clinical Sichuan Baili Pharmaceutical Co Ltd Head and Neck Neoplasms; Solid tumours; Stomach Neoplasms; Squamous Cell Carcinoma of Head and Neck; Neoplasms, Glandular and Epithelial; Triple Negative Breast Neoplasms; Digestive System Neoplasms; Colorectal Neoplasms; Carcinoma, Squamous Cell; Esophageal Squamous Cell Carcinoma; Carcinoma, Non-Small-Cell Lung Details
CM-93 CM-93 Phase 1 Clinical Shanghai Crimson Pharmaceutical Co Ltd Glioblastoma Details
Tarloxotinib Bromide PR-610; TH-4000; SN-33999 Phase 2 Clinical Threshold Solid tumours; Squamous Cell Carcinoma of Head and Neck; Carcinoma, Non-Small-Cell Lung Details
Sutetinib Maleate Phase 2 Clinical Jiangsu Maidu Pharmaceutical R & D Co Ltd, Jiangsu Suzhong Pharma Group Co Ltd Solid tumours; Carcinoma, Non-Small-Cell Lung Details
DBPR-112 DBPR-112; ABT-101 Phase 2 Clinical National Health Research Institutes Head and Neck Neoplasms; Solid tumours; Lung Neoplasms; Carcinoma, Non-Small-Cell Lung Details
Ametumumab SY-101 Phase 2 Clinical Institute of Bioengineering Academy of Military Medical Sciences Chinese People's Liberation Army, Shanghai Serum Bio-Technology Co Ltd Solid tumours; Colorectal Neoplasms Details
BAY-2927088 BAY-2927088; BAY2927088 Phase 1 Clinical Bayer Healthcare Company Ltd, Bayer AG Carcinoma, Non-Small-Cell Lung Details
MRG003 MRG-003 Phase 3 Clinical Shanghai Miracogen Inc Head and Neck Neoplasms; Biliary Tract Neoplasms; Solid tumours; Stomach Neoplasms; Esophageal Neoplasms; Squamous Cell Carcinoma of Head and Neck; Neoplasms; Nasopharyngeal Carcinoma; Colorectal Neoplasms; Bile Duct Neoplasms; Carcinoma, Non-Small-Cell Lung Details
MCLA-129 MCLA-129 Phase 2 Clinical Merus Nv Solid tumours; Head and Neck Neoplasms; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Colorectal Neoplasms; Esophageal Squamous Cell Carcinoma; Carcinoma, Non-Small-Cell Lung Details
DK-2-10 DK210 Phase 1 Clinical Deka Biosciences Inc Solid tumours; Kidney Neoplasms; Head and Neck Neoplasms; Carcinoma, Renal Cell; Pancreatic Neoplasms; Skin Neoplasms; Neoplasms; Colorectal Neoplasms; Genital Neoplasms, Female; Carcinoma, Non-Small-Cell Lung Details
HA121-28 HA121-28; SYHA121-28 Phase 3 Clinical CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co Ltd Biliary Tract Neoplasms; Solid tumours; Esophageal Neoplasms; Neoplasms; Medullary thyroid cancer (MTC); Bile Duct Neoplasms; Lung Neoplasms; Carcinoma, Non-Small-Cell Lung Details
BB-1705 BB-1705 Phase 2 Clinical Solid tumours; Neoplasms; Neoplasm Metastasis Details
AZD9592 AZD9592; AZD-9592 Phase 1 Clinical Astrazeneca Plc Head and Neck Neoplasms; Solid tumours; Carcinoma, Non-Small-Cell Lung Details
TQ-B3395 TQ-B3395; CT-1495; TQ-B-3395 Phase 1 Clinical Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd, Beijing Centaurus Biopharma Co Ltd Neoplasms; Breast Neoplasms Details
ES-072 ES-072 Phase 1 Clinical Zhejiang Bosheng Pharmaceutical Co Ltd Carcinoma, Non-Small-Cell Lung Details
HLX-35 HLX-35 Phase 1 Clinical Shanghai Henlius Biologics Co Ltd Solid tumours; Carcinoma, Non-Small-Cell Lung Details
Depatuxizumab mafodotin ABT-414/806; ABT-414 Phase 3 Clinical Abbvie Inc Glioblastoma; Gliosarcoma; Glioma; Carcinoma, Squamous Cell Details
Serclutamab talirine ABBV-321 Phase 1 Clinical Abbvie Inc Neoplasms Details
Cetuximab biosimilar (Shanghai Henlius Biotech) HLX-05; JZB-29; JZB-28 Phase 1 Clinical Shanghai Henlius Biotech Inc Squamous Cell Carcinoma of Head and Neck; Colorectal Neoplasms Details
JNJ-26483327 JNJ-26483327; MTKi-327; BGB-102 Phase 2 Clinical Johnson & Johnson Solid tumours; Neoplasms; Macular Degeneration Details
WTS-004 WTS-004 Phase 1 Clinical Hangzhou Wutong Tree Pharmaceutical Co Ltd Carcinoma, Non-Small-Cell Lung Details
Pimurutamab HLX-07 Phase 2 Clinical Shanghai Henlius Biotech Inc Solid tumours; Carcinoma, Renal Cell; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Esophageal Neoplasms; Neoplasms; Small Cell Lung Carcinoma; Carcinoma, Adenosquamous; Nasopharyngeal Carcinoma; Colorectal Neoplasms; Carcinoma, Squamous Cell; Esophageal Squamous Cell Carcinoma; Lung Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung Details
Varlitinib Ditosylate QBT-01; ARRY-543; SPS-4370; ASLAN-001; ARRY-334543 Phase 2 Clinical Array Biopharma Solid tumours; Biliary Tract Neoplasms; Stomach Neoplasms; Neoplasms; Pancreatic Neoplasms; Cholangiocarcinoma; Breast Neoplasms; Bile Duct Neoplasms Details
Mefatinib Phase 3 Clinical Suzhou Maitai Bio-Technology Co Ltd Solid tumours; Carcinoma, Non-Small-Cell Lung Details

This web search service is supported by Google Inc.

totop
Call us
Call us
North America:
+1 800-810-0816 (Toll Free)
Asia & Pacific:
+86 400-682-2521
Fax
Fax
+1 888-377-6111
Address
Address
1 Innovation Way, Newark, DE 19711, USA

Leave a message